Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deciphera Pharmaceuticals (DE:D05)
FRANKFURT:D05
RESEARCH TOOLSreports
Deciphera Pharmaceuticals (D05) Ownership - Who Owns Deciphera Pharmaceuticals?
0 Followers
Deciphera Pharmaceuticals (D05) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
33.01% Other Institutional Investors
66.99% Public Companies and
Individual Investors
The ownership structure of Deciphera Pharmaceuticals (DE:D05) stock is a mix of institutional, retail and individual investors. Approximately 33.01% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 66.99% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 24, 2024 | Brightstar Associates Llc >10% Owner | Bought | $481 |
| Feb 20, 2024 | Matthew Sherman Evp & Chief Medical Officer | Sold | $40820 |
| Feb 20, 2024 | Sold | $46986 | |
| Feb 20, 2024 | Jama Pitman Svp, Chief Development Officer | Sold | $35388 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $170494 | |
| Mar 31, 2024 | Bought | $1006060 | |
| Mar 31, 2024 | Bought | $6391335 | |
| Mar 31, 2024 | Sold | $9306606 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,010,595 | Institution | ― | 76,240,308 | |
| 330,505 | Institution | ― | 8,369,709 | |
| 305,120 | Institution | ― | 7,726,859 | |
| 58,585 | Institution | ― | 1,483,607 | |
| 2,626,043 | Institution | ― | 66,501,913 | |
| 2,788 | Institution | ― | 70,603 | |
| 852 | Institution | ― | 21,576 | |
| 1,771,969 | Institution | ― | 44,873,343 | |
| 23,710 | Institution | ― | 600,432 | |
| 629 | Institution | ― | 15,929 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 30,611 | Institution | ― | 775,193 | |
| 5,037 | Institution | ― | 127,557 | |
| 214,151 | Institution | ― | 5,423,160 | |
| 2,800 | Institution | ― | 70,907 | |
| 1,822 | Institution | ― | 46,140 | |
| 56,507 | Institution | ― | 1,430,983 | |
| 12,298 | Institution | ― | 311,435 | |
| 10,628 | Institution | ― | 269,143 | |
| 59,257 | Institution | ― | 1,500,624 | |
| 37,045 | Institution | ― | 938,128 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Deciphera Pharmaceuticals (DE:D05)?
According to the latest TipRanks data, approximately 33.01% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 66.99% is held by retail investors.
What percentage of Deciphera Pharmaceuticals (DE:D05) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.01% of Deciphera Pharmaceuticals (DE:D05) stock is held by institutional investors.
What percentage of Deciphera Pharmaceuticals (DE:D05) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.99% of Deciphera Pharmaceuticals (DE:D05) stock is held by retail investors.
Who owns the most shares of Deciphera Pharmaceuticals (DE:D05)?
Vanguard owns the most shares of Deciphera Pharmaceuticals (DE:D05).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.